These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30639878)

  • 1. Amantadine enhances nigrostriatal and mesolimbic dopamine function in the rat brain in relation to motor and exploratory activity.
    Nikolaus S; Wittsack HJ; Beu M; Antke C; Hautzel H; Wickrath F; Müller-Lutz A; De Souza Silva MA; Huston JP; Antoch G; Müller HW
    Pharmacol Biochem Behav; 2019 Apr; 179():156-170. PubMed ID: 30639878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of D-cycloserine and amantadine on motor behavior and D
    Nikolaus S; Wittsack HJ; Wickrath F; Müller-Lutz A; Hautzel H; Beu M; Antke C; Mamlins E; De Souza Silva MA; Huston JP; Antoch G; Müller HW
    Sci Rep; 2019 Nov; 9(1):16128. PubMed ID: 31695055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain.
    Nikolaus S; Wittsack HJ; Beu M; Antke C; De Souza Silva MA; Wickrath F; Müller-Lutz A; Huston JP; Antoch G; Müller HW; Hautzel H
    Front Behav Neurosci; 2018; 12():38. PubMed ID: 29593508
    [No Abstract]   [Full Text] [Related]  

  • 4. The 5-HT
    Nikolaus S; Wittsack HJ; Beu M; Hautzel H; Antke C; Mamlins E; Cardinale J; Decheva C; Huston JP; Antoch G; Giesel FL; Müller HW
    Pharmacol Biochem Behav; 2022 Apr; 215():173363. PubMed ID: 35227734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic Modulation of Nigrostriatal and Mesolimbic Dopamine and Motor/Exploratory Behaviors in the Rat.
    Nikolaus S; Wittsack HJ; Antke C; Beu M; Hautzel H; Decheva C; Mamlins E; Mori Y; Huston JP; Antoch G; Müller HW
    Front Neurosci; 2021; 15():682398. PubMed ID: 34456668
    [No Abstract]   [Full Text] [Related]  

  • 6. GABAergic and glutamatergic effects on nigrostriatal and mesolimbic dopamine release in the rat.
    Nikolaus S; Beu M; Wittsack HJ; Müller-Lutz A; Antke C; Hautzel H; Mori Y; Mamlins E; Antoch G; Müller HW
    Rev Neurosci; 2020 Aug; 31(6):569-588. PubMed ID: 32619197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABAergic control of neostriatal dopamine D
    Nikolaus S; Beu M; de Souza Silva MA; Huston JP; Antke C; Müller HW; Hautzel H
    Pharmacol Biochem Behav; 2017 Feb; 153():76-87. PubMed ID: 28012732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DAT versus D2 receptor binding in the rat striatum: l-DOPA-induced motor activity is better predicted by reuptake than release of dopamine.
    Nikolaus S; Beu M; Angelica De Souza Silva M; Huston JP; Hautzel H; Antke C; Müller HW
    Synapse; 2016 Sep; 70(9):369-77. PubMed ID: 27164322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of chronic nicotine administration on dopaminergic receptor binding sites in rat nigrostriatal and mesolimbic regions.
    Fung YK; Lau YS
    Gen Pharmacol; 1991; 22(1):117-9. PubMed ID: 2050279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.
    Koulu M; Lappalainen J; Hietala J; Sjöholm B
    Psychopharmacology (Berl); 1990; 101(2):168-71. PubMed ID: 2140903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
    Koob GF; Simon H; Herman JP; Le Moal M
    Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of chronic ethanol consumption on the mesolimbic and nigrostriatal dopamine systems.
    Pellegrino SM; Druse MJ
    Alcohol Clin Exp Res; 1992 Apr; 16(2):275-80. PubMed ID: 1534209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nigrostriatal and Mesolimbic D
    Stark AJ; Smith CT; Lin YC; Petersen KJ; Trujillo P; van Wouwe NC; Kang H; Donahue MJ; Kessler RM; Zald DH; Claassen DO
    J Neurosci; 2018 Mar; 38(13):3230-3239. PubMed ID: 29483278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different interactions of prolyl oligopeptidase and neurotensin in dopaminergic function of the rat nigrostriatal and mesolimbic pathways.
    Peltonen I; Myöhänen TT; Männistö PT
    Neurochem Res; 2012 Sep; 37(9):2033-41. PubMed ID: 22729983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between L-DOPA-Induced Reduction in Motor and Exploratory Activity and Striatal Dopamine D2 Receptor Binding in the Rat.
    Nikolaus S; Beu M; de Souza Silva MA; Huston JP; Hautzel H; Mattern C; Antke C; Müller HW
    Front Behav Neurosci; 2015; 9():352. PubMed ID: 26778989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study.
    Lategan AJ; Marien MR; Colpaert FC
    Life Sci; 1992; 50(14):995-9. PubMed ID: 1372673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems.
    Healy DJ; Meador-Woodruff JH
    Brain Res; 1996 Feb; 708(1-2):38-44. PubMed ID: 8720857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan).
    Costall B; Naylor RJ
    Psychopharmacologia; 1975 Jul; 43(1):53-61. PubMed ID: 1099605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity of dopamine transmission in the rat striatum after treatment with the NMDA receptor antagonist amantadine.
    Peeters M; Page G; Maloteaux JM; Hermans E
    Brain Res; 2002 Sep; 949(1-2):32-41. PubMed ID: 12213297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
    Broderick PA; Piercey MF
    J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.